BioCentury | Apr 15, 2013
Strategy

IP armamentarium

With the most stocked clinical pipeline among its RNAi peers, Alnylam Pharmaceuticals Inc. has made the leap from platform to products, building on an IP position that has enabled revenue-generating deals that footed the bill...
BC Extra | Mar 29, 2011
Financial News

Marina planning follow-on

Marina Biotech Inc. (NASDAQ:MRNA) proposed late Friday to raise $15 million through the sale of units in a follow-on. Further details were not disclosed. Marina (formerly MDRNA Inc. ) was up $0.01 to $0.69 on Monday....
BC Week In Review | Aug 30, 2010
Company News

Cypress, Marina Biotech deal

Cypress acquired Marina's patent rights and technology related to an intranasal formulation of carbetocin. Cypress expects to start Phase II testing in 1Q11 for the long-acting analog of oxytocin to treat autism. Marina will receive...
BC Week In Review | Aug 23, 2010
Company News

Cequent, Marina Biotech deal

Marina (formerly MDRNA Inc. ) disclosed in its 2Q10 earnings that it completed its previously announced acquisition of RNAi company Cequent in a stock deal. Cequent received 9.9 million Marina Biotech shares, valued at $31.6 million...
BC Week In Review | Aug 2, 2010
Company News

Marina Biotech, University of Helsinki deal

Marina (formerly MDRNA Inc. ) and the university extended by two years to June 2012 a 2008 deal to screen Marina's Trp Cage phage display library for peptides that Marina will use to improve and increase...
BC Week In Review | Aug 2, 2010
Financial News

Marina Biotech financial update

MDRNA Inc. implemented a 1-for-4 reverse stock split, changed its name to Marina Biotech Inc. and began trading under the symbol "MRNAD." Following the split, the company will have 12.2 million shares outstanding. Marina Biotech...
BC Week In Review | Aug 2, 2010
Company News

Marina Biotech, novosom deal

Marina (formerly MDRNA Inc. ) acquired novosom's Smarticles liposomal-based delivery technology for 1.4 million shares of Marina stock, valued at $3.8 million based on Marina's close of $2.67 on July 27, the day before the deal...
BC Week In Review | Jun 14, 2010
Company News

MDRNA, RiboTask deal

The companies added exclusive rights to develop and commercialize diagnostics using RiboTask's unlocked nucleobase analog (UNA) technology to a 2009 deal granting MDRNA rights to use the technology for human therapeutics. MDRNA said the expanded...
BC Week In Review | May 17, 2010
Clinical News

MDRNA preclinical data

In mice, systemic delivery of 80 µg/kg UsiRNA targeting Factor VII in the liver resulted in 50% inhibition of Factor VII protein activity. Data were presented at the BIO International Conference in Chicago. The compound...
BC Week In Review | May 17, 2010
Clinical News

MDRNA preclinical data

In a mouse model of orthotopic bladder cancer, intravesical delivery of UsiRNAs targeting fibroblast growth factor-3 (FGF-3; INT2 ) and survivin in a single formulation reduced both tumor bioluminescence and survivin mRNA expression by about 30%...
Items per page:
1 - 10 of 317
BioCentury | Apr 15, 2013
Strategy

IP armamentarium

With the most stocked clinical pipeline among its RNAi peers, Alnylam Pharmaceuticals Inc. has made the leap from platform to products, building on an IP position that has enabled revenue-generating deals that footed the bill...
BC Extra | Mar 29, 2011
Financial News

Marina planning follow-on

Marina Biotech Inc. (NASDAQ:MRNA) proposed late Friday to raise $15 million through the sale of units in a follow-on. Further details were not disclosed. Marina (formerly MDRNA Inc. ) was up $0.01 to $0.69 on Monday....
BC Week In Review | Aug 30, 2010
Company News

Cypress, Marina Biotech deal

Cypress acquired Marina's patent rights and technology related to an intranasal formulation of carbetocin. Cypress expects to start Phase II testing in 1Q11 for the long-acting analog of oxytocin to treat autism. Marina will receive...
BC Week In Review | Aug 23, 2010
Company News

Cequent, Marina Biotech deal

Marina (formerly MDRNA Inc. ) disclosed in its 2Q10 earnings that it completed its previously announced acquisition of RNAi company Cequent in a stock deal. Cequent received 9.9 million Marina Biotech shares, valued at $31.6 million...
BC Week In Review | Aug 2, 2010
Company News

Marina Biotech, University of Helsinki deal

Marina (formerly MDRNA Inc. ) and the university extended by two years to June 2012 a 2008 deal to screen Marina's Trp Cage phage display library for peptides that Marina will use to improve and increase...
BC Week In Review | Aug 2, 2010
Financial News

Marina Biotech financial update

MDRNA Inc. implemented a 1-for-4 reverse stock split, changed its name to Marina Biotech Inc. and began trading under the symbol "MRNAD." Following the split, the company will have 12.2 million shares outstanding. Marina Biotech...
BC Week In Review | Aug 2, 2010
Company News

Marina Biotech, novosom deal

Marina (formerly MDRNA Inc. ) acquired novosom's Smarticles liposomal-based delivery technology for 1.4 million shares of Marina stock, valued at $3.8 million based on Marina's close of $2.67 on July 27, the day before the deal...
BC Week In Review | Jun 14, 2010
Company News

MDRNA, RiboTask deal

The companies added exclusive rights to develop and commercialize diagnostics using RiboTask's unlocked nucleobase analog (UNA) technology to a 2009 deal granting MDRNA rights to use the technology for human therapeutics. MDRNA said the expanded...
BC Week In Review | May 17, 2010
Clinical News

MDRNA preclinical data

In mice, systemic delivery of 80 µg/kg UsiRNA targeting Factor VII in the liver resulted in 50% inhibition of Factor VII protein activity. Data were presented at the BIO International Conference in Chicago. The compound...
BC Week In Review | May 17, 2010
Clinical News

MDRNA preclinical data

In a mouse model of orthotopic bladder cancer, intravesical delivery of UsiRNAs targeting fibroblast growth factor-3 (FGF-3; INT2 ) and survivin in a single formulation reduced both tumor bioluminescence and survivin mRNA expression by about 30%...
Items per page:
1 - 10 of 317